PMC:7441777 / 49513-51434
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T105 | 311-314 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T77 | 87-95 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T78 | 98-107 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T79 | 279-287 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T80 | 843-851 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T81 | 1274-1282 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T82 | 1552-1560 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T83 | 1779-1787 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T84 | 1900-1908 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T85 | 1911-1920 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T324 | 58-59 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T325 | 136-137 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T326 | 181-182 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T327 | 526-529 | http://purl.obolibrary.org/obo/CLO_0009325 | denotes | TF1 |
T328 | 1203-1204 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T329 | 1506-1507 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T46875 | 42-52 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T22320 | 210-221 | Chemical | denotes | polyphenols | http://purl.obolibrary.org/obo/CHEBI_26195 |
T80937 | 237-246 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T24344 | 357-368 | Chemical | denotes | polyphenols | http://purl.obolibrary.org/obo/CHEBI_26195 |
T98962 | 515-519 | Chemical | denotes | EGCG | http://purl.obolibrary.org/obo/CHEBI_4806 |
T71966 | 568-578 | Chemical | denotes | hesperidin | http://purl.obolibrary.org/obo/CHEBI_28775 |
T90398 | 585-594 | Chemical | denotes | myricetin | http://purl.obolibrary.org/obo/CHEBI_18152|http://purl.obolibrary.org/obo/CHEBI_58395 |
T23792 | 601-614 | Chemical | denotes | quercetagetin | http://purl.obolibrary.org/obo/CHEBI_8695 |
T42245 | 632-642 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
T90588 | 744-746 | Chemical | denotes | MM | http://purl.obolibrary.org/obo/CHEBI_53458|http://purl.obolibrary.org/obo/CHEBI_74707 |
T93177 | 877-888 | Chemical | denotes | polyphenols | http://purl.obolibrary.org/obo/CHEBI_26195 |
T65194 | 1083-1089 | Chemical | denotes | ligand | http://purl.obolibrary.org/obo/CHEBI_52214 |
T29242 | 1142-1144 | Chemical | denotes | MM | http://purl.obolibrary.org/obo/CHEBI_53458|http://purl.obolibrary.org/obo/CHEBI_74707 |
T73139 | 1169-1173 | Chemical | denotes | EGCG | http://purl.obolibrary.org/obo/CHEBI_4806 |
T70168 | 1246-1250 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T25385 | 1251-1261 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
T98626 | 1475-1479 | Chemical | denotes | EGCG | http://purl.obolibrary.org/obo/CHEBI_4806 |
T66579 | 1727-1738 | Chemical | denotes | polyphenols | http://purl.obolibrary.org/obo/CHEBI_26195 |
T46661 | 1760-1770 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T39 | 311-326 | http://purl.obolibrary.org/obo/GO_0039703 | denotes | RNA replication |
T40 | 826-835 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | formation |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1524 | 37-41 | Gene | denotes | RdRp | Gene:43740578 |
1525 | 290-294 | Gene | denotes | RdRp | Gene:43740578 |
1526 | 510-514 | Gene | denotes | RdRp | Gene:43740578 |
1527 | 521-525 | Gene | denotes | RdRp | Gene:43740578 |
1528 | 531-535 | Gene | denotes | RdRp | Gene:43740578 |
1529 | 542-546 | Gene | denotes | RdRp | Gene:43740578 |
1530 | 547-551 | Gene | denotes | TF2b | Gene:2959 |
1531 | 553-557 | Gene | denotes | RdRp | Gene:43740578 |
1532 | 563-567 | Gene | denotes | RdRp | Gene:43740578 |
1533 | 580-584 | Gene | denotes | RdRp | Gene:43740578 |
1534 | 596-600 | Gene | denotes | RdRp | Gene:43740578 |
1535 | 627-631 | Gene | denotes | RdRp | Gene:43740578 |
1536 | 1181-1185 | Gene | denotes | TF2b | Gene:2959 |
1537 | 1285-1289 | Gene | denotes | RdRp | Gene:43740578 |
1538 | 1487-1491 | Gene | denotes | TF2b | Gene:2959 |
1539 | 1540-1544 | Gene | denotes | RdRp | Gene:43740578 |
1540 | 854-858 | Gene | denotes | RdRp | Gene:43740578 |
1541 | 1790-1794 | Gene | denotes | RdRp | Gene:43740578 |
1542 | 279-289 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
1543 | 843-853 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
1544 | 1274-1284 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
1545 | 1552-1562 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
1546 | 1779-1789 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
1547 | 210-221 | Chemical | denotes | polyphenols | MESH:D059808 |
1548 | 357-368 | Chemical | denotes | polyphenols | MESH:D059808 |
1549 | 632-642 | Chemical | denotes | remdesivir | MESH:C000606551 |
1550 | 877-888 | Chemical | denotes | polyphenols | MESH:D059808 |
1551 | 1145-1149 | Chemical | denotes | PBSA | MESH:C437084 |
1552 | 1169-1173 | Chemical | denotes | EGCG | MESH:C045651 |
1553 | 1251-1261 | Chemical | denotes | remdesivir | MESH:C000606551 |
1554 | 1322-1326 | Chemical | denotes | ADME | |
1555 | 1475-1479 | Chemical | denotes | EGCG | MESH:C045651 |
1556 | 1727-1738 | Chemical | denotes | polyphenols | MESH:D059808 |
1557 | 87-107 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
1558 | 1339-1347 | Disease | denotes | toxicity | MESH:D064420 |
1559 | 1900-1920 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
LitCovid-PD-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glyco_epitope_db_id |
---|---|---|---|---|---|
T16 | 526-529 | GlycoEpitope | denotes | TF1 | http://www.glycoepitope.jp/epitopes/AN0049 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T520 | 0-2 | Sentence | denotes | 4. |
T521 | 4-15 | Sentence | denotes | Conclusions |
T522 | 16-327 | Sentence | denotes | Keeping in mind that RdRp inhibitors play a crucial role to combat the SARS-CoV-2 infection, in this work, we performed a comprehensive molecular docking study with a library of hundred natural polyphenols with potential antiviral properties that may inhibit the SARS-CoV-2 RdRp and prevent the RNA replication. |
T523 | 328-447 | Sentence | denotes | We shortlisted eight natural polyphenols having binding energy −7.0 kcal/mol or less for molecular dynamics simulation. |
T524 | 448-789 | Sentence | denotes | Further, we performed 150 ns molecular dynamics simulation of RdRp/EGCG, RdRp/TF1, RdRp/TF2a, RdRp/TF2b, RdRp/TF3, RdRp/hesperidin, RdRp/myricetin, RdRp/quercetagetin, along with RdRp/remdesivir complex and computed the binding energies by the molecular mechanics-Poisson-Boltzmann surface area (MM-PBSA) scheme from last 50 ns trajectories. |
T525 | 790-1010 | Sentence | denotes | Our study suggests that the complex formation of the SARS-CoV-2 RdRp and eight natural polyphenols is favoured by the intermolecular van der Waals and electrostatic interactions as well as nonpolar solvation free energy. |
T526 | 1011-1098 | Sentence | denotes | We have also investigated the hotspot residues controlling the receptor-ligand binding. |
T527 | 1099-1290 | Sentence | denotes | Finally, molecular dynamics simulation and MM-PBSA study reveals that EGCG, TF2a, TF2b, and TF3 possess a better binding affinity than the control drug remdesivir against the SARS-CoV-2 RdRp. |
T528 | 1291-1431 | Sentence | denotes | Further, we also looked at the ADME prediction, toxicity prediction, and target analysis to assess their druggability of the five compounds. |
T529 | 1432-1606 | Sentence | denotes | The obtained results strongly suggest that EGCG, TF2a, TF2b, and TF3 have a stable binding affinity towards RdRp of the SARS-CoV-2 with favourable pharmacokinetic properties. |
T530 | 1607-1680 | Sentence | denotes | These bioactive compounds exhibit broad ranges of therapeutic properties. |
T531 | 1681-1795 | Sentence | denotes | Therefore, we believe that these four natural polyphenols can act as potential inhibitors for the SARS-CoV-2 RdRp. |
T532 | 1796-1921 | Sentence | denotes | However, further in vitro and in vivo studies need to be carried out to validate their efficacy against SARS-CoV-2 infection. |